Corporate Support and Scientific Integrity

To the Editor:

I read with great interest and appreciation the letter from Dr. Irwin Nash in the March/April 2007 issue of The Hematologist. The issue he described was one of the major reasons for ASH starting its Development Task Force, which I had the privilege to chair from 2003 to 2005. The idea was to try to get away from the Society's dependence on the drug and instrument companies, which have greatly enriched the Society's treasury.

I was especially pleased to have initiated the Henry and Lillian Stratton endowment and the Stratton-Jaffé Scholar Award programs, which have served to support the independent funding of training and research programs and that led to the Clinical Research Training Institute.

I hope, therefore, that the Society's members, officers, and staff will continue their efforts in this direction.

Sincerely yours,

Ernst R. Jaffé, MD
1983 ASH President

Return to Top

Letters to the Editor — Solicitation

The Hematologist welcomes letters of up to 200 words. These letters may be in response to editorials or on any subject of interest to our readers. Please include a postal address, e-mail address, and phone number. Publication will be based on editorial decisions regarding interest to readers and space availability. We may edit letters for reasons of space or clarity. The Hematologist reserves the right to publish your letter, unless it is labeled "not for publication."

Letters should be sent to:

Karen Learner, Managing Editor
The Hematologist: ASH News and Reports
1900 M Street, NW, Suite 200
Washington, DC 20036
klearner@hematology.org

Return to Top

Return to Table of Contents